ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

Cause Of Allergic Reaction To Cetuximab Found

March 28, 2008

NCI CTEP Approved Trials For the Month of April

April 26, 2013

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

January 28, 2011

In Brief: Cancer Bill Nearly Became Law Without Nixon’s Signature as Impeachment Obsesses White House

August 2, 1974

Cancer Panel: Lack Of Genetic Basis For Race Presents Dilemma For Studies; Data Collection Must Include Socioeconomic Measures, Report To Clinton Says

March 20, 1998